Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 20;12(1):6489.
doi: 10.1038/s41598-022-10334-5.

Exhaled nitric oxide in early rheumatoid arthritis and effects of methotrexate treatment

Tomas Weitoft  1   2   3 , Anders Lind  4 , Anders Larsson  5 , Johan Rönnelid  6 , Marieann Högman  7
Affiliations

Exhaled nitric oxide in early rheumatoid arthritis and effects of methotrexate treatment

Tomas Weitoft et al. Sci Rep. .

Abstract

Patients with established rheumatoid arthritis (RA) and disease modifying treatments have lower nitric oxide (NO) levels in the alveolar compartment (CANO) and in the airway wall (CawNO), but also higher diffusion capacities for NO in the airways (DawNO) compared to matched controls. The aim of the present study was to investigate the NO lung dynamics in patients with recent onset RA before and after immune suppression with methotrexate therapy. Patients with early RA and antibodies against anticitrullinated peptides (ACPA) were recruited. Measurement of exhaled NO and inflammatory markers in serum were performed. Clinical disease activity was evaluated with Disease Activity Score for 28 joints. Healthy individuals were used as matched controls. Data are presented as median (lower quartile, upper quartile) values. RA patients (n = 44) had lower exhaled NO (FENO50) 16 (10-24) ppb compared to controls 21 (15, 29) ppb, p = 0.013. In NO-dynamics, CANO was lower in RA patients 1.6 (1.0, 2.2) ppb compared to the control subjects 2.3 (1.3, 3.1) ppb, p = 0.007. CawNO was also lower in the RA patients 55 (24, 106) ppb compared to control subjects 124 (110, 170) ppb, p < 0.001, but DawNO was higher 17 (8, 30) mL/s and 9 (5, 11) mL/s respectively, p < 0.001. Methotrexate treatment for three months reduced disease activity, but did not change the NO dynamics. In conclusion, the altered NO dynamics of the lung in ACPA-positive RA patients are already present in the early stages of the disease before any treatments and do not change after methotrexate therapy suggesting a role in the pathogenesis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Flowchart of included and excluded patients in protocol A and B of the study.
See this image and copyright information in PMC

References

    1. Boucher JL, Moali C, Tenu JP. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol. Life Sci. 1999;55(8–9):1015–1028. doi: 10.1007/s000180050352. - DOI - PMC - PubMed
    1. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur. Respir. J. 1993;6(9):1368–1370. - PubMed
    1. Högman M, Holmkvist T, Wegener T, et al. Extended NO analysis applied to patients with COPD, allergic asthma and allergic rhinitis. Respir. Med. 2002;96:24–30. doi: 10.1053/rmed.2001.1204. - DOI - PubMed
    1. Damiani G, Pacifico A, Rizzi M, Santus P, Bridgewood C, Bragazzi NL, Adawi M, Watad A. Patients with psoriatic arthritis have higher levels of FENO than those with only psoriasis, which may reflect a higher prevalence of a subclinical respiratory involvement. Clin. Rheumatol. 2020;39:2981–2988. doi: 10.1007/s10067-020-05050-2. - DOI - PubMed
    1. Tiev KP, Coste J, Ziani M, et al. Diagnostic value of exhaled nitric oxide to detect interstitial lung disease in systemic sclerosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2009;26(1):32–38. - PubMed

Publication types